Bacterial Meningitis - Lumbar Puncture - Procalcitonin

Home > Browse Topics

Pediatric Bacterial Meningitis: An Update on Early Identification and Management

Bacterial Meningitis - Lumbar Puncture - Procalcitonin - Cover

Pediatric Bacterial Meningitis: An Update on Early Identification and Management

Facebook - Bacterial Meningitis - Lumbar Puncture - Procalcitonin Twitter - Bacterial Meningitis - Lumbar Puncture - Procalcitonin Linkedin - Bacterial Meningitis - Lumbar Puncture - Procalcitonin

  About This Issue

Since bacterial meningitis can present with many signs and symptoms, differentiation of bacterial meningitis from viral meningitis and from other mimics can be difficult. If the presentation is not “classic” in nature, diagnostic and therapeutic delay can occur, frequently with devastating consequences. This issue provides evidence-based recommendations for the early identification and appropriate management of bacterial meningitis in pediatric patients. You will learn:

•  The most common causative pathogens, based on patient age
•  Typical clinical findings that are consistent with bacterial meningitis and how they vary for patients in different age groups
•  Which physical examination findings indicate that a patient should undergo lumbar puncture
•  Inflammatory markers in the serum and cerebrospinal fluid, such as procalcitonin, can help detect serious bacterial illness
•  How clinical prediction scores, such as the bacterial meningitis score, can help distinguish between bacterial meningitis and viral meningitis
•  Which antibiotic are recommended, and when they should be started
•  The potential benefits of adjunct therapies, such as corticosteroids, and when they are indicated

  Issue Information

Author: Emerson Posadas, MD, MBA; Jay Fisher, MD, FAAP, FACEP

Peer Reviewers: Sheldon L. Kaplan, MD; Lise Nigrovic, MD, MPH

Publication Date: November 1, 2018

CME Expiration Date: November 1, 2021

CME Credits: AMA PRA Category 1 CreditsTM, 4 ACEP Category I Credits, 4 AAP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits. Included as part of the 4 credits, this CME activity is eligible for 4 Infectious Disease CME credits. 

PubMed ID: 30358380

  Issue Features
  Table of Contents
  1. Abstract
  2. Case Presentations
  3. Introduction
  4. Critical Appraisal of the Literature
  5. Etiology and Pathophysiology
    1. Causative Pathogens and Mechanisms of Infection
  6. Differential Diagnosis
  7. Prehospital Care
  8. Emergency Department Evaluation
    1. History
    2. Physical Examination
      1. Neck Findings
      2. Skin Findings
      3. Findings That Indicate a Patient Should Undergo Lumbar Puncture
  9. Diagnostic Studies
    1. Scoring Systems
    2. Serum Studies
      1. Procalcitonin
    3. Lumbar Puncture
      1. Cerebrospinal Fluid Analysis
    4. Imaging
  10. Treatment and Complications
    1. Initial Approach
    2. Intravenous Fluids
    3. Antimicrobial Therapy
      1. Empiric Antimicrobial Therapy
      2. Antimicrobial Therapy for Patients Aged < 1 Month
      3. Antimicrobial Therapy for Patients Aged ≥ 1 Month
    4. Neurologic Complications
  11. Special Circumstances
    1. Aseptic Meningitis
    2. Lyme Meningitis
    3. Tuberculous Meningitis
    4. Immunocompromised State
    5. Penetrating Trauma or Recent Neurosurgery
    6. Concurrent Urinary Tract Infection
  12. Controversies and Cutting Edge
    1. Corticosteroids
  13. Disposition
  14. Summary
  15. Risk Management Pitfalls in the Management of Pediatric Patients With Bacterial Meningitis
  16. Time- And Cost-Effective Strategies
  17. Case Conclusions
  18. Clinical Pathway for the Management of Pediatric Patients With Suspected Bacterial Meningitis
  19. Tables
    1. Table 1. Pathogens That Cause Bacterial Meningitis, Based on Patient Age
    2. Table 2. Bacterial Meningitis Score for Children
  20. References



The presentation of bacterial meningitis can overlap with viral meningitis and other conditions, and emergency clinicians must remain vigilant to avoid delaying treatment for a child with bacterial meningitis. Inflammatory markers, such as procalcitonin, in the serum and cerebrospinal fluid may help distinguish between bacterial meningitis and viral meningitis. Appropriate early antibiotic treatment and management for bacterial meningitis is critical for optimal outcomes. Although debated, corticosteroids should be considered in certain cases. This issue provides evidence-based recommendations for the early identification and appropriate management of bacterial meningitis in pediatric patients.


Case Presentations

On a warm day in June, an unvaccinated 9-year-old girl is sent to your ED. Earlier that day, she was seen at her primary care physician’s office by a physician assistant who reported that the child had headache and fever intermittently for 3 to 4 days. The PA was concerned that she might have meningitis. The patient arrives, ambulatory and alert, complaining of a bitemporal headache. Her fever at home was 38.3°C (101°F). There has been no photophobia or rash, and there are no ill contacts. The child took acetaminophen 2 hours prior to arrival. On physical examination, the child is tired but not toxic-appearing. She had an episode of vomiting in triage. Her vital signs are: temperature, 38.7°C (101.6°F); heart rate, 142 beats/min; respiratory rate, 22 breaths/min; blood pressure, 119/77 mm Hg; and oxygen saturation, 95% on room air. Her pain score is 8/10. Her physical examination is notable for head and neck discomfort when moving from sitting to the supine position. Her neck has full range of motion and she is negative for Kernig sign and Brudzinski sign. The remainder of her examination is normal. The patient is given a 20 mL/kg normal saline bolus IV, 6 mg ondansetron IV, and 10 mg/kg ibuprofen orally. An hour later, her vital signs are: temperature, 37.2°C (99°F); heart rate, 126 beats/min; respiratory rate, 20 breaths/min; and blood pressure 111/67 mm Hg. Her pain score is now 4/10. Her peripheral white blood cell count is 16,000 with a left shift, and her chemistry is notable only for a glucose level of 146 mg/dL. Given the girl’s lack of frank meningismus and improvement with ibuprofen, is a lumbar puncture indicated? What are the most common causes of meningitis in this age group? Should antibiotics be given?

A 4-month-old boy presents with a history of cough, pallor, fever to 38.9°C (102°F), and decreased feeding on the morning of presentation. The infant drank 6 ounces about 4 hours before arrival, but would not feed at presentation. The boy’s parents state he did not vomit or have diarrhea. His past medical history is notable for cesarean delivery at 36 weeks' gestation. There was prolonged rupture of membranes and he was hospitalized for 3 days after delivery. The boy’s parents report no prior illnesses, and his immunizations are up-to-date. On physical examination, the boy’s vital signs are: temperature, 38.9°C (99.6°F); heart rate, 158 beats/min; respiratory rate, 50 breaths/min; and oxygen saturation, 98% on room air. The boy is arousable but sleepy and does not fix and follow. His fontanel is flat. His HEENT examination is notable for nasal congestion with mucus secretions. The boy’s cardiopulmonary and abdominal examinations are unremarkable. The boy’s capillary refill is < 2 seconds, but his muscle tone is decreased. He is fussy during the examination. Is this merely an upper respiratory infection or should meningitis be considered? What are common clinical features of meningitis in this age group? What further management is indicated? Which empiric antibiotics—if any—are indicated at this time?



Bacterial meningitis in children is one of the most high-risk diagnostic and management challenges for the emergency clinician. Widespread implementation of vaccination strategies against pneumococcal, meningococcal, and Haemophilus influenzae type b diseases has led to a dramatic decline in the frequency of this condition over the past 3 decades.1,2 In some ways, however, this has made the early identification of bacterial meningitis more difficult for the emergency clinician. The rare occurrence of the condition means that a high-volume pediatric emergency clinician may evaluate only 1 child with bacterial meningitis every 3 to 5 years. Since bacterial meningitis can present with many signs and symptoms, differentiation of bacterial meningitis from viral meningitis and from other mimics can be difficult. If the presentation is not “classic” in nature, diagnostic and therapeutic delay can occur, frequently with devastating consequences. Inflammatory markers in the serum and cerebrospinal fluid, such as procalcitonin, may help distinguish between bacterial meningitis and viral meningitis. Children with suspected bacterial meningitis should be treated early and aggressively. Adjunct therapies such as corticosteroids are still highly debated but may be indicated in select cases. Until better diagnostic tools and therapies are established, emergency clinicians must remain vigilant to avoid treatment delays for a child with bacterial meningitis.

This issue of Pediatric Emergency Medicine Practice reviews the classic clinical findings associated with bacterial meningitis, offers guidance for using studies and scoring systems to aid in the diagnosis of bacterial meningitis, and provides evidence-base recommendations for the management of patients with bacterial meningitis.


Critical Appraisal of the Literature

A literature search was performed in PubMed and the Cochrane Database of Systematic Reviews using the search terms: pediatric bacterial meningitis, viral meningitis, pediatric lumbar puncture, neonatal fever, antibiotics for pediatric meningitis, and pediatric meningitis diagnostic studies. A total of 98 articles published between 1992 and 2018 were reviewed.

The literature regarding bacterial meningitis management and therapy contains multiple multicenter trials and systematic reviews presenting strong evidence. More-recent articles, including several prospective cohort studies, have evaluated novel markers of bacterial meningitis.


Risk Management Pitfalls in the Management of Pediatric Patients With Bacterial Meningitis

2. “The patient has inflamed tympanic membranes. The fever and irritability are likely due to otitis media. It’s not meningitis.”

Many young children with bacterial meningitis can have concomitant inflammation in other areas on physical examination or diagnostic study. Otitis media and upper respiratory tract infections are common enough conditions that their presence can lead the emergency clinician to “explain away” the child’s more serious symptoms as being due to those pathophysiologic findings. Anchoring on a simpler, less severe diagnosis can result in missing or delaying the correct diagnosis.

6. “The patient likely has viral meningitis, so we don't need to get a lumbar puncture.”

The notion that emergency clinicians can distinguish the difference between viral and bacterial meningitis based on the history and physical examination is not supported by the available evidence. The clinical overlap of these conditions is substantial, particularly early in the course of illness. Diagnosis should not be made based on the history and physical examination alone.

8. “We need to wait for a CT scan and lumbar puncture before we can give antibiotics, as they can cause sterilization of CSF.”

When caring for a patient with a presumptive diagnosis of bacterial meningitis, do not delay administration of appropriate antibiotics for the completion of a CT scan or lumbar puncture or for the results of these studies. Although antibiotics may obscure the ultimate bacteriologic diagnosis, this is a small clinical price to pay to prevent further bacterial proliferation and inflammation within the CNS.



Bacterial Meningitis - Lumbar Puncture - Procalcitonin - Table 1. Pathogens That Cause Bacterial Meningitis, Based on Patient Age




Evidence-based medicine requires a critical appraisal of the literature based upon study methodology and number of patients. Not all references are equally robust. The findings of a large, prospective, randomized, and blinded trial should carry more weight than a case report.

To help the reader judge the strength of each reference, pertinent information about the study is included in bold type following the reference, where available. In addition, the most informative references cited in this paper, as determined by the author, are highlighted.

  1. McIntyre PB, O'Brien KL, Greenwood B, t al. Effect of vaccines on bacterial meningitis worldwide. Lancet. 2012;380:1703-1711. (Review)
  2. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016-2025. (Multicenter retrospective analysis)
  3. Brouwer MC, van de Beek D. Epidemiology of community-acquired bacterial meningitis. Curr Opin Infect Dis. 2018;31(1):78-84. (Review)
  4. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244-256. (Population study; 1379 cases)
  5. American Academy of Pediatrics. In: Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village: American Academy of Pediatrics; 2015. (Society recommendations and guidelines)
  6. Berardi A, Rossi C, Lugli L, et al. Group B Streptococcus late-onset disease: 2003-2010. Pediatrics. 2013;131(2):e361-e368. (Prospective cohort study)
  7. Bartlett AW, Smith B, George CR, et al. Epidemiology of late and very late onset Group B streptococcal disease: fifteen-year experience from two Australian tertiary pediatric facilities. Pediatr Infect Dis J. 2017;36(1):20-24. (Retrospective chart review)
  8. Shattuck KE, Chonmaitree T. The changing spectrum of neonatal meningitis over a fifteen-year period. Clin Pediatr (Phila). 1992;31(3):130-136. (Review)
  9. Nigrovic LE, Kuppermann N, Malley R, et al. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med. 2008;15(6):522-528. (Retrospective review; 231 patients)
  10. Johansson Kostenniemi U, Norman D, Borgstrom M, et al. The clinical presentation of acute bacterial meningitis varies with age, sex and duration of illness. Acta Paediatr. 2015;104(11):1117-1124. (Registry review)
  11. Romain AS, Cohen R, Plainvert C, et al. Clinical and laboratory features of Group B Streptococcus meningitis in infants and newborns: study of 848 cases in France from 2001-2014. Clin Infect Dis. 2017; 66(6):857-864. (Database case review; 848 cases)
  12. Levy M, Wong E, Fried D. Diseases that mimic meningitis. Analysis of 650 lumbar punctures. Clin Pediatr (Phila). 1990;29(5):254-255. (Retrospective review; 650 patients)
  13. Feldman KW, Sugar NF, Browd SR. Initial clinical presentation of children with acute and chronic versus acute subdural hemorrhage resulting from abusive head trauma. J Neurosurg Pediatr. 2015;16(2):177-185. (Multicenter retrospective review; 383 children)
  14. Spies EL, Klevens J. Fatal abusive head trauma among children aged <5 years - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2016;65(20):505-509. (Database analysis)
  15. Nemer JA, Tallick SA, O’Connor RE, et al. Emergency medical services transport of patients with headache: mode of arrival may indicate serious etiology. Prehosp Emerg Care. 1998;2(4):304-307. (Observational; 937 patients)
  16. Gainza-Lein M, Sanchez Fernandez I, Jackson M, et al. Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus. JAMA Neurol. 2018;75(4):410-418. (Prospective cohort study; 218 patients)
  17. Klein JO, Feigin RD, McCracken GH Jr. Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics. 1986;78(5 Pt 2):959-982. (Review)
  18. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR-2):1-28. (Review)
  19. Wu HM, Harcourt BH, Hatcher CP, et al. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N Engl J Med. 2009;360(9):886-892. (Case report; 3 patients)
  20. Curtis S, Stobart K, Vandermeer B, et al. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010;126(5):952-960. (Systematic review)
  21. Walsh-Kelly C, Nelson DB, Smith DS, et al. Clinical predictors of bacterial versus aseptic meningitis in childhood. Ann Emerg Med. 1992;21(8):910-914. (Prospective; 172 patients)
  22. Geiseler J, Nelson KE. Bacterial meningitis without clinical signs of meningeal irritation. Southern Med J 1982;75(4):448-450. (Review)
  23. Vincent J, Thomas K, Mathew O. An improved clinical method for detecting meningeal irritation. Arch Dis Child. 1993;68(2):215-218. (Clinical method)
  24. Oostenbrink R, Moons KG, Theunissen CC, et al. Signs of meningeal irritation at the emergency department: how often bacterial meningitis? Pediatr Emerg Care. 2001;17(3):161-164. (Chart review; 326 patients)
  25. Carpenter RR, Petersdorf RG. The clinical spectrum of bacterial meningitis. Am J Med. 1962;33:262-275. (Review)
  26. Aronson PL, McCulloh RJ, Tieder JS, et al. Application of the Rochester criteria to identify febrile infants with bacteremia and meningitis. Pediatr Emerg Care. 2018. DOI: (Retrospective cohort study; 82 patients)
  27. Patwari AK, Singh BS, Manorama DE. Inappropriate secretion of antidiuretic hormone in acute bacterial meningitis. Ann Trop Paediatr. 1995;15(2):179-183. (Prospective study; 60 patients)
  28. Gaieski DF, O’Brien NF, Hernandez R. Emergency neurologic life support: meningitis and encephalitis. Neurocrit Care. 2017;27(Suppl 1):124-133. (Review)
  29. Bonsu BK, Harper MB. A low peripheral blood white blood cell count in infants younger than 90 days increases the odds of acute bacterial meningitis relative to bacteremia. Acad Emerg Med. 2004;11(12):1297-1301. (Evaluation study; 72 patients)
  30. Chiu NC, Chi H, Peng CC, et al. Retrospective study of prognostic factors in pediatric invasive pneumococcal disease. PeerJ. 2017;5:e2941. (Retrospective study)
  31. Cruz AT, Mahajan P, Bonsu BK, et al. Accuracy of complete blood cell counts to identify febrile infants 60 days or younger with invasive bacterial infections. JAMA Pediatr. 2017;171(11):e172927. (Prospective observational cohort study; 4313 patients)
  32. Milcent K, Faesch S, Gras-Le Guen C, et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr. 2016;170(1):62-69. (Prospective cohort study; 2047 infants)
  33. Hubert-Dibon G, Danjou L, Feildel-Fournial C, et al. Procalcitonin and C-reactive protein may help to detect invasive bacterial infections in children who have fever without source. Acta Paediatr. 2018;107(7):1262-1269. (Prospective cohort study; 1060 patients)
  34. Julian-Jimenez A, Candel-Gonzalez FJ, Gonzalez Del Castillo J. [Usefulness of inflammation and infection biomarkers in the emergency department]. Enferm Infecc Microbiol Clin. 2014;32(3):177-190. (Review)
  35. Casado MI, Alonso FM, Pinedo BL, et al. Acute meningitis in the pediatric emergency department: diagnostic yield of procalcitonin and C-reactive protein. Pediatr Emerg Care. 2014;30(11):849-850. (Retrospective study; 85 patients with acute meningitis)
  36. Dubos F, Korczowski B, Aygun DA, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med. 2008;162(12):1157-1163. (Retrospective cohort study; 198 patients)
  37. Hu R, Gong Y, Wang Y. Relationship of serum procalcitonin levels to severity and prognosis in pediatric bacterial meningitis. Clin Pediatr (Phila). 2015;54(12):1141-1144. (Prospective study; 82 children)
  38. Aydemir C, Aydemir H, Kokturk F, et al. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis. BMC Pediatr. 2018;18(1):253. (Prospective cohort study; 480 patients)
  39. Jain S, Cheng J, Alpern ER, et al. Management of febrile neonates in US pediatric emergency departments. Pediatrics. 2014;133(2):187-195. (Cross-sectional study; 2253 neonates)
  40. Gomez B, Mintegi S, Bressan S, et al. Validation of the “Step-by-Step” approach in the management of young febrile infants. Pediatrics. 2016;138(2):1-10. (Prospective; 2185 infants)
  41. Mintegi S, Gomez B, Martinez-Virumbrales L, et al. Outpatient management of selected young febrile infants without antibiotics. Arch Dis Child. 2017;102(3):244-249. (Prospective cohort study; 1472 patients)
  42. Carraccio CL LM, Fisher MP. Limp as a presenting sign of meningitis. Pediatr Inf Dis J. 1990;9(9):673-674. (Case report)
  43. Fisher JD. Insidious presentation of pediatric pneumococcal meningitis: alive and well in the post vaccine era. Am J Emerg Med. 2009;27(9):1173e5-1773e7. (Case report)
  44. Hegenbarth MA, Green M, Rowley AH, et al. Absent or minimal cerebrospinal fluid abnormalities in Haemophilus influenzae meningitis. Pediatr Emerg Care. 1990;6(3):191-194. (Retrospective review; 379 cases)
  45. Moss RB, Sosulski R. Early meningitis. Clin Pediatr (Phila). 1991;30(4):229-230. (Review)
  46. Asano Y, Yoshikawa T, Suga S, et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics. 1994;93(1):104-108. (Prospective study; 176 infants)
  47. Nigrovic LE, Kuppermann N, Malley R. Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-Haemophilus influenzae era. Pediatrics. 2002;110(4):712-719. (Comparative study; 696 patients)
  48. Kestenbaum LA, Ebberson J, Zorc JJ, et al. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics. 2010;125(2):257-264. (Cross-sectional study; 380 patients)
  49. Freedman SB, Marrocco A, Pirie J, et al. Predictors of bacterial meningitis in the era after Haemophilus influenzae. Arch Pediatr Adolesc Med. 2001;155(12):1301-1306. (Retrospective analysis of CSF samples; 44 cases of bacterial meningitis)
  50. Thomson J, Sucharew H, Cruz AT, et al. Cerebrospinal fluid reference values for young infants undergoing lumbar puncture. Pediatrics. 2018;141(3);e20173405. (Cross-sectional study; 7766 patients)
  51. X Sáez-Llorens. Meningitis. In: Krugman's Infectious Diseases of Children. 11th ed. Krugman S, Gershon AA, Hotez PJ, et al, eds. Philadelphia, PA: Mosby; 2004. (Textbook chapter)
  52. Moss RB, Sosulski R. Early meningitis. Clin Pediatr. 1991;30(4):229-230. (Review)
  53. Srinivasan L, Kilpatrick L, Shah SS, et al. Cerebrospinal fluid cytokines in the diagnosis of bacterial meningitis in infants. Pediatr Res. 2016;80(4):566-572. (Prospective cohort study; 684 infants)
  54. Reshi Z, Nazir M, Wani W, et al. Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates. J Perinatol. 2017;37(8):927-931. (Prospective cohort study; 36 patients)
  55. Shokrollahi MR, Shabanzadeh K, Noorbakhsh S, et al. Diagnostic value of CRP, procalcitonin, and ferritin levels in cerebrospinal fluid of children with meningitis. Cent Nerv Syst Agents Med Chem. 2018;18(1):58-62. (Prospective cross-sectional study; 57 children)
  56. Ingram WB. Medical Malpractice Verdicts, Settlements & Experts. Triple L Publications; 2017. Available at: Accessed October 15, 2018. (Legal database reference)
  57. Nigrovic LE, Malley R, Macias CG, et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics. 2008;122(4):726-730. (Retrospective chart review; 231 patients)
  58. Rennick G, Shann F, de Campo J. Cerebral herniation during bacterial meningitis in children. BMJ. 1993;306(6883):953-955. (Retrospective review; 445 children)
  59. Singhi SC, Singhi PD, Srinivas B, et al. Fluid restriction does not improve the outcome of acute meningitis. Pediatr Infect Dis J. 1995;14(6):495-503. (Randomized controlled trial; 50 children)
  60. Maconochie IK, Bhaumik S. Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev. 2016;11:CD004786. (Cochrane review; 3 trials, 420 children)
  61. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001;108(5):1169-1174. (Retrospective review; 128 patients)
  62. Coant PN, Kornberg AE, Duffy LC, et al. Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care. 1992;8(4):200-205. (Comparative study; 178 patients)
  63. Scholz H, Hofmann T, Noack R, et al. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children. Chemotherapy. 1998;44(2):142-147. (Prospective multicenter study; 82 patients)
  64. Prasad K, Kumar A, Gupta PK, et al. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev. 2007(4):CD001832. (Cochrane review; 19 trials, 1496 patients)
  65. Sinner SW, Tunkel AR. Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin North Am. 2004;18(3):581-602. (Review)
  66. van de Beek D, Brouwer MC, Thwaites GE, et al. Advances in treatment of bacterial meningitis. Lancet. 2012;380(9854):1693-1702. (Review)
  67. Feldman EA, McCulloh RJ, Myers AL, et al. Empiric antibiotic use and susceptibility in infants with bacterial infections: a multicenter retrospective cohort study. Hosp Pediatr. 2017;7(8):427-435. (Multicenter retrospective cohort study; 470 infants)
  68. Uppal L, Singhi S, Singhi P, et al. Role of rifampin in reducing inflammation and neuronal damage in dhildhood bacterial meningitis: a pilot randomized controlled trial. Pediatr Infect Dis J. 2017;36(6):556-559. (Randomized controlled trial; 40 children)
  69. Kim KS. Bacterial meningitis beyond the neonatal period. 7th ed. Philadelphia: Elsevier Saunders; 2014. (Review)
  70. Guedj R, Chappuy H, Titomanlio L, et al. Do all children who present with a complex febrile seizure need a lumbar puncture? Ann Emerg Med. 2017;70(1):52-62 e56. (Retrospective study; 7 pediatric EDs, 839 patients with complex febrile seizure)
  71.  Michelson KA, Lyons TW, Johnson KB, et al. Utility of lumbar puncture in children presenting with status epilepticus. Pediatr Emerg Care. 2017;33(8):544-547. (Retrospective cross-sectional study; 126 patients)
  72. Kaplan SL, Woods CR. Neurologic complications of bacterial meningitis in children. Curr Clin Top Infect Dis. 1992;12:37-55. (Review)
  73. Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med. 1984;311(14):869-874. (Prospective study; 185 patients)
  74. Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics. 2000;105(2):316-319. (Retrospective chart review; 158 cases of meningitis)
  75. Logan SA, MacMahon E. Viral meningitis. BMJ. 2008;336(7634):36-40. (Review)
  76. Zakhour R, Aguilera E, Hasbun R, et al. Risk classification for enteroviral infection in children with meningitis and negative Gram stain. Pediatr Emerg Care. 2016. DOI: (Retrospective review; 137 children)
  77. Wallace SS, Lopez MA, Caviness AC. Impact of enterovirus testing on resource use in febrile young infants: a systematic review. Hosp Pediatr. 2017;7(2):96-102. (Review)
  78. Kaewpoowat Q, Salazar L, Aguilera E, et al. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection. 2016;44(3):337-345. (Retrospective review; 98 adults)
  79. Caviness AC, Demmler GJ, Almendarez Y, et al. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr. 2008;153(2):164-169. (Comparative study; 5817 patients)
  80. Bergstrom T, Vahlne A, Alestig K, et al. Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis. 1990;162(2):322-330. (Prospective study; 27 patients)
  81. Gubler DJ. Arboviruses as imported disease agents: the need for increased awareness. Arch Virol Suppl. 1996;11:21-32. (Review)
  82. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310(3):308-315. (Review)
  83. Abzug MJ. Viral Meningitis and Encephalitis. In: Current Pediatric Therapy, 18th ed. Burg FD, Ingelfinger JR, Polin RA, et al eds. Philadelphia, PA: Saunders. 2006. (Textbook chapter)
  84. Shah SS, Zaoutis TE, Turnquist J, et al. Early differentiation of Lyme from enteroviral meningitis. Pediatr Infect Dis J. 2005;24(6):542-545. (Cross-sectional study; 24 patients with Lyme meningitis and 151 patients with enteroviral meningitis)
  85. Chiang SS, Khan FA, Milstein MB, et al. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(10):947-957. (Syetematic review and meta-analysis; 19 studies)
  86. Schoeman JF, Donald PR. Tuberculous meningitis. Handb Clin Neurol. 2013;112:1135-1138. (Review)
  87. Chavez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52(3):795-810. (Review)
  88. Fong IW, Tomkins KB. Review of Pseudomonas aeruginosa meningitis with special emphasis on treatment with ceftazidime. Rev Infect Dis. 1985;7(5):604-612. (Review)
  89. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284. (Practice guidelines)
  90. Thomson J, Cruz AT, Nigrovic LE, et al. Concomitant bacterial meningitis in infants with urinary tract infection. Pediatr Infect Dis J. 2017;36(9):908-910. (Retrospective study; 1737 infants)
  91. Wallace SS, Brown DN, Cruz AT. Prevalence of concomitant acute bacterial meningitis in neonates with febrile urinary tract infection: a retrospective cross-sectional study. J Pediatr. 2017;184:199-203. (Retrospective cross-sectional study; 236 patients)
  92. Banniettis N, Joshi S, Kaushik S, et al. Diagnostic practices for suspected community-acquired central nervous system infection in the post-conjugate vaccine era. Pediatr Emerg Care. 2017. DOI: (Observational retrospective; 940 patients)
  93. Young BR, Nguyen THP, Alabaster A, et al. The prevalence of bacterial meningitis in febrile infants 29-60 days with positive urinalysis. Hosp Pediatr. 2018;8(8):450-457. (Retrospective cohort study; 833 patients)
  94. Ogunlesi TA, Odigwe CC, Oladapo OT. Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis. Cochrane Database Syst Rev. 2015(11):CD010435. (Cochrane review; 2 trials, 132 participants)
  95. Brouwer MC, McIntyre P, Prasad K, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015(9):CD004405. (Cochrane review; 25 studies, 4121 participants)
  96. Molyneux E, Riordan FA, Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children’s Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Ann Trop Paediatr. 2006;26(1):29-37. (Cross-sectional study; 24 patients)
  97. McCracken GH Jr. Rich nations, poor nations, and bacterial meningitis. Lancet. 2002;360(9328):183. (Review)
  98. Mongelluzzo J, Mohamad Z, Ten Have TR, et al. Corticosteroids and mortality in children with bacterial meningitis. JAMA. 2008;299(17):2048-2055. (Multicenter observational study; 2780 children)
  CME Information

Accreditation: EB Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ACCME.

Credit Designation: EB Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Specialty CME: Included as part of the 4 credits, this CME activity is eligible for 4 Infectious Disease credits, subject to your state and institutional approval.

Faculty Disclosures: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The information received is as follows: Dr. Posadas, Dr. Fisher, Dr. Nigrovic, Dr. Mishler, Dr. Skrainka, Dr. Claudius, Dr. Horeczko, and their related parties report no significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation. Dr. Kaplan made the following disclosure: Pfizer grant. Dr. Jagoda made the following disclosures: Consultant, Daiichi Sankyo Inc; Consultant, Pfizer Inc; Consultant, Banyan Biomarkers Inc; Consulting fees, EB Medicine.

Commercial Support: This issue of Pediatric Emergency Medicine Practicedid not receive any commercial support.

  Related Links

To view this issue, please choose one of the options below:

Purchase a
Pediatric Emergency Medicine Practice
Purchase issue and
CME test (4 credits)
Pediatric Emergency Medicine Practice
single issue
Sign up for a free trial
Free 48-hour trial
Pediatric Emergency Medicine Practice

2018 LLSA Prep Study Guides, 35 CME Credits

About EB Medicine:
Accredited By:
Endorsed By:
HONcode HONcode


Last Modified: 11/16/2018
© EB Medicine